COMPARISON OF P53, KI-67, BCL-2 AND HER2-NEU BIOMARKERS FREQUENCY IN DIFFERENT GRADES OF PROSTATIC CARCINOMA

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

ALIZAMIR A.; MONSEF A.R.; JAFARI M.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Avicenna Journal of Clinical Medicine Year:2014 | Volume:21 | Issue:3 (SN 73) Page(s): 203-210

Download Full-Text

Persian Verion

View:

498

Download:

Cites:

Information Journal Paper

Title

COMPARISON OF P53, KI-67, BCL-2 AND HER2-NEU BIOMARKERS FREQUENCY IN DIFFERENT GRADES OF PROSTATIC CARCINOMA

Author(s)

ALIZAMIR A. | MONSEF A.R. | JAFARI M. | Issue Writer Certificate

Keywords

BIOLOGICAL MARKERSQ2

PROSTATIC NEOPLASMSQ2

Abstract

Introduction & Objective: Prostatic carcinoma is the most common malignancy throughout the world among the males over middle age and the second leading cause of cancer-related deaths in western countries. The currently most established prognostic factors in prostatic carcinoma are histological grade (Gleason system) and tumor stage .Various new prognostic factors that have been suggested to provide additional information include proliferative activity (Ki-67 labeling index),over expression of the oncogene bcl2 and Her2-neu and inactivation of the p53 tumor suppressor gene. The aim of this study was to compare p53, Ki-67, bcl2 and Her2-neu biomarkers frequency in low grade and high grade prostatic carcinoma. Materials& Methods: In this cross sectional study, 76 cases of prostatic carcinoma patients with different combined Gleason score were studied after they had been admitted to the pathology wards of Beheshti and Be’sat hospital in Hamadan city between 2006-2011.Age, Combined Gleason's score and histologic grade record in each case. p53, Ki-67, bcl2 and Her2-neu expression were investigated immunohistochemically .The biomarkers of p53, Ki-67, bcl2 and Her2-neu between low grade and high grade prostatic carcinoma were compared. The tumors were considered low grad when Gleason score was 6 or less, and high grad when the Gleason score was 7 to 10.Results: This investigation revealed that the frequency of p53, bcl2, Her2-neu and Ki-67 expression is 68.4%, 34.2%, 78.9% and 52.6%, respectively. In this study 81.6% of high grade and 55.3% of low grade tumors were immunoreactive for p53 (P=0.013). Over expression of bcl2 was found in 36.8% of high grade and 31.6% of low grade of prostatic carcinoma (P=0.405). 81.6% of high grade and 76.3% of low grade carcinoma were positive for Her2 – neu (P=0.390). Ki-67 positivity was found in 68.4% of high grade and 36.8% low grade carcinoma (P=0.006).Conclusion: The most important findings of our study are that the frequency of p53 and Ki-67 proteins expression is correlated with high grade of prostatic carcinoma. However, there was not any significant difference of bcl2 and Her2-neu biomarker in the two grades of prostatic carcinoma.

Cites

No record.

References

No record.

Cite

APA: Copy

ALIZAMIR, A., MONSEF, A.R., & JAFARI, M.. (2014). COMPARISON OF P53, KI-67, BCL-2 AND HER2-NEU BIOMARKERS FREQUENCY IN DIFFERENT GRADES OF PROSTATIC CARCINOMA. AVICENNA JOURNAL OF CLINICAL MEDICINE (SCIENTIFIC JOURNAL OF HAMADAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES), 21(3 (SN 73) ), 203-210. SID. https://sid.ir/paper/17930/en

Vancouver: Copy

ALIZAMIR A., MONSEF A.R., JAFARI M.. COMPARISON OF P53, KI-67, BCL-2 AND HER2-NEU BIOMARKERS FREQUENCY IN DIFFERENT GRADES OF PROSTATIC CARCINOMA. AVICENNA JOURNAL OF CLINICAL MEDICINE (SCIENTIFIC JOURNAL OF HAMADAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES)[Internet]. 2014;21(3 (SN 73) ):203-210. Available from: https://sid.ir/paper/17930/en

IEEE: Copy

A. ALIZAMIR, A.R. MONSEF, and M. JAFARI, “COMPARISON OF P53, KI-67, BCL-2 AND HER2-NEU BIOMARKERS FREQUENCY IN DIFFERENT GRADES OF PROSTATIC CARCINOMA,” AVICENNA JOURNAL OF CLINICAL MEDICINE (SCIENTIFIC JOURNAL OF HAMADAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES), vol. 21, no. 3 (SN 73) , pp. 203–210, 2014, [Online]. Available: https://sid.ir/paper/17930/en

Related Journal Papers